| 摘要 |
The invention refers to compounds having antiinflammatory activity characterized by the formula <IMG> I or a stereoisomeric component thereof, wherein the 1,2-position is saturated or is a double bond X1 is selected from hydrogen, fluorine, chlorine and bromine X2 is selected from hydrogen, fluorine, chlorine and bromine R1 is selected from hydrogen or a straight or branched hydrocarbon chain having 1 to 4 carbon atoms R2 is selected from hydrogen or straight and branched hydrocarbon chains having 1 to 10 carbon atoms and R3 is selected from <IMG> Y is O or S R4 is selected from hydrogen, straight or branched hydrocarbon chains having 1 to 10 carbon atoms or from phenyl R5 is selected from hydrogen or methyl and R6 is selected from hydrogen, straight or branched, saturated or unsaturated hydrocarbon chains having 1 to 10 carbon atoms, an alkyl group substituted by at least one halogen atom, a heterocyclic ring system containing 3 to 10 atoms in the ring system, <IMG> (m=0,1,2; n=2,3,4,5,6), phenyl or benzyl groups which are unsubstituted or substituted by one or more alkyl, nitro, carboxy, alkoxy, halogen, cyano, carbalkoxy or trifluoromethyl group(s), provided that when R2 is hydrogen R1 is a straight or branched hydrocarbon chain having 1 to 4 carbon atoms. The invention also refers to a process and intermediates for the preparation of these compounds, a pharmaceutical preparation containing one of the compounds and a method for the treatment of inflammatory conditions.
|
